CORONAVIRUS CLINICAL TRIALS
Study 1: Pfizer - A Phase 1, Open-Label Dose-Finding Study To Evaluate Safety, Tolerability, And Immunogenicity And Phase 2/3 Placebo Controlled, Observer-Blinded Safety, Tolerability, And Immunogenicity Study Of A SARS-COV-2 RNA Vaccine Candidate Against COVID-19 In Healthy Children 2- 5 years of age.

Study 2: Moderna - A Phase 2/3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adolescents 12 to < 18 years of age.

Study 3:  A Multicenter COVID-19 Study Conducted to Evaluate the Performance of the LumiraDx SARS-CoV-2 Ag Ultra Test at Point of Care Testing Sites.

For more information, call
Cyn3rgy Research at
​503 907 2179 x2

Sign Up for one of our studies!